Beyond established prognostic and clinical parameters such as Gleason score, PSA or tumor stage, reliable biomarkers for the prognostication of high risk PCa are still lacking, especially those further explaining high risk PCa biology. The gene discussed is KLK3; the disease is posterior cortical atrophy.